Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
09/2003
09/25/2003WO2003078418A1 3-hydroxy-3-(2-thienyl)propionamide compound, process for producing the same, and process for producing 3-amino-1-(2-thienyl)-1-propanol compound therefrom
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181734 Process for the preparation of 2-nitrothiophene selectively from thiophene using metal exchanged clay catalysts
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003US20030181319 Process for preparing nonracemic chiral alcohols
09/25/2003US20030181318 Process for preparing nonracemic chiral alcohols
09/25/2003US20030180804 (Serine) protease modulators; membrane proteins
09/25/2003US20030180236 Resorcinol derivatives
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1346991A1 Process for the preparation of 2-nitrothiophene selectively from thiophene using metal exchanged clay catalysts
09/24/2003EP1346977A1 Method for producing aryl-aminopropanols
09/24/2003EP1346971A1 Production method for biarylalanine
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624196 Particularly gelatinase A, collagenase-3, and stromelysin-1 and for the treatment of multiple sclerosis, cardiovascular disorders
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624177 Treating diseases in which matrix melatoproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076388A2 Bis-aniline derivatives useful as potassium channels modulators
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002038557A9 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
09/18/2003US20030176628 Polythiophenes formed form monomers such as (2,3-dihydro-thieno(3,4-b)(1,4)dioxin-2-yl-methoxy)-acetic acid, for use as coatings, printable pastes or electroconductive layers
09/18/2003US20030176490 Benzo(b)thiophene derivatives and process for producing the same
09/18/2003US20030176489 Glyt-1 inhibitors
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/17/2003EP1344109A2 Onium salts and the use therof as latent acids
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443161A Aryl sulfonamides as serotonin antagonist for treatment of obesity
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1121401C Aminophenol derivates
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS)
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620837 1-Benzothiophene derivatives
09/16/2003US6620835 Method of inhibiting matrix metalloproteinases
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620767 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074478A1 Process for the preparation of biaryl compounds
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074459A1 Process for producing carbonyl compound
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003052572A3 System and method for displaying editorial content through television navigation controls and electronic program guides
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2003002522A3 Peptide deformylase inhibitors
09/12/2003CA2481550A1 Process for producing carbonyl compound
09/12/2003CA2477728A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/12/2003CA2477392A1 Methods for treating diseases related to intraocular pressure
09/11/2003WO2003074572A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/11/2003US20030171595 Thienylsulphonylamino(thio)carbonyl compounds
09/11/2003US20030171592 A nitro ketone or a cyano ketone is reacted with a hydrogen-donor in the presence of a transition metal compound catalyst having an optically active nitrogen asymmetric ligand to form the alcohol and reducing to the amine
09/11/2003US20030171589 Method for preparing sulfone or sulfoxide compound
09/11/2003US20030171585 Anti-inflammatory compounds
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171420 Using a thiolactomycin compound as parasiticide
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171350 Sulphonamide derivatives
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/11/2003US20030171213 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an
09/11/2003US20030170561 An acid- dissociable group-containing polysiloxane and a photoacid generator containing a trifluoromethane sulfonic acid or other fluoroalkyl sulfonic acid compounds
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 329